Skip to main content
. 2015 Mar 19;10(3):e0119409. doi: 10.1371/journal.pone.0119409

Table 2. Patient demographics, clinical characteristics, and the measured perfusion defect volumes.

Patient no. Sex Age NIHSS Time from onset to imaging [hh:mm] NCCT ASPECTS Intracranial Occlusion & side Truncation Ischemic core derived from 48 seconds data [ml] Ischemic core derived from 210 seconds data[ml] Ischemic penumbra derived from 48 seconds data [ml] Ichemic penumbra derived from 210 seconds data [ml] Perfusion Abnormality derived from 48 seconds data [ml] Perfusion Abnormality derived from 210 seconds data [ml] Follow up infarct core* [ml] Atrial fibrillation Cardiac ejection fraction <40% Ipsilateral extracranial ICA stenosis or occlusion Ipsilateral extracranial ICA dissection
1 Male 38 12 01:53 7 M2 R Tissue TAC 18.2 10.0 59.5 66.0 77.7 76.1 16.3 No No No Yes, (both) sides)
2 Female 66 23 04:39 8 M1 R Tissue TAC 13.3 3.3 44.4 53.3 57.7 56.5 53.0 Yes No No No
3 Male 61 15 03:00 8 M2 R Tissue TAC 22.5 8.7 70.3 82.9 92.8 91.7 10.8 No No No Yes, (both sides)
4 Male 67 12 01:17 8 M1 R VOF 53.2 47.7 3.8 14.5 57.0 62.3 63.5 Yes No No No
5 Male 72 23 00:38 9 M1 L Tissue TAC 86.7 83.7 3.0 7.4 89.7 91.2 118.8 No No No No
6 Male 54 11 03:15 9 M1 R No 18.1 9.7 26.7 49.6 44.8 59.2 63.8 No No No No
7 Male 63 6 01:18 10 M1 L Tissue TAC 25.5 10.0 52.6 68.6 78.1 78.6 Not available No No Yes No
8 Female 34 18 01:17 8 ICA & M1 L Tissue TAC 24.6 1.7 46.8 66.9 71.5 68.6 59.9 No No No No
9 Female 67 17 01:54 9 M1 R Tissue TAC 51.8 43.8 11.8 22.4 63.6 66.2 87.2 No No No No
10 Female 64 13 03:21 10 M2 L Tissue TAC 0.6 0.0 2 1.5 24.8 22.2 24.8 11.6 No No No No
11 Male 39 21 01:15 5 M1 L Tissue TAC 25.1 19.6 14.5 13.2 39.6 32.8 35.7 No No No No
12 Female 54 16 04:17 8 M1 L Tissue TAC 17.6 0.0 61.6 78.3 79.2 78.4 17.3 No No No No
13 Male 52 11 01:43 10 ICA, & M1 L VOF 33.9 6.8 35.2 64.0 69.1 70.8 20.2 No No Yes No
14 Male 66 22 01:45 10 M L1 VOF 57.1 15.7 19.6 64.3 76.7 80.0 1.4 No No No No
15 Female 86 21 Not available 8 M1 R AIF &VOF 65.4 34.5 0.9 3.7 66.3 38.2 111.4 Yes No No No
16 Male 82 23 01:16 7 M1 L AIF & VOF 50.0 12.4 0.0 51.1 50.0 63.4 4.1 Yes No Yes No
17 Female 75 4 Not available 9 M1 R VOF 12.5 0.6 12.7 24.9 25.2 25.5 8.5 Yes No No No
18 Female 48 12 01:48 10 M1 R No 0.9 0.2 19.5 23.5 20.4 23.7 1.9 No No No No
19 Male 45 16 01:06 10 M1 R Tissue TAC 39.0 7.3 40.6 70.1 79.6 77.4 31.5 No No No Yes
20 Female 44 14 03:13 6 M2 L No 1.6 2.5 69.5 71.4 71.1 73.8 0.0 No No No No
21 Male 49 28 04:31 3 M1 L Tissue TAC 37.1 19.6 32.4 48.6 69.6 68.1 60.9 No No No No
22 Male 51 25 02:21 8 M1 L Tissue TAC 17.7 0.1 69.4 86.3 87.1 86.4 45.1 No Yes No No
23 Female 82 20 02:21 10 ICA & M1 R Tissue TAC 67.8 55.8 16.2 35.0 84.1 90.8 Not available No No No Yes
24 Female 64 13 01:51 10 m1 L No 10.4 8.4 36.5 40.1 46.9 48.5 Not available No No Yes No
25 Male 51 26 02:00 7 m2 L Tissue TAC 2.2 0.0 44.4 45.2 46.6 45.2 6.0 No No No Yes
26 Female 67 17 02:56 10 a1 L Tissue TAC 1.0 0.6 0.1 0.3 1.2 0.9 5.4 No No No No
27 Female 47 12 04:10 7 m1 R Tissue TAC 35.2 13.3 40.6 67.2 75.8 80.5 Not available No No No No
28 Female 84 19 02:50 8 m1 L VOF 53.7 0.5 16.6 66.9 70.3 67.4 Not available No No No No
29 Female 47 13 01:20 9 m1 L No 11.2 8.4 38.3 39.1 49.4 47.5 9.9 Yes No No No
30 Male 60 16 01:57 4 m1 L Tissue TAC 93.6 39.4 5.5 67.1 99.0 106.5 227.3 No Yes No No
31 Female 78 12 04:46 6 m1 L Tissue TAC 41.2 26.2 95.7 110.9 136.9 137.1 192.1 Yes No No No
32 Male 66 16 02:38 10 m2 R Tissue TAC 70.8 12.5 104.5 156.6 175.3 169.1 40.0 No No No No
33 Female 60 16 02:35 4 m1 L Tissue TAC 73.3 56.1 78.4 89.6 151.7 145.7 19.0 No No No No
34 Male 58 6 Not available 10 m1 L Tissue TAC 41.5 12.4 84.6 114.9 126.2 127.2 51.7 No No Yes Yes
35 Female 80 5 02:24 7 M2 L Tissue TAC 11.2 7.2 136.0 141.7 147.1 149.0 115.3 No No No No
36 Male 70 25 01:14 9 M1 L Tissue TAC 24.1 11.6 34.2 46.4 58.3 58.0 276.1 No No No No

TAC: tissue attenuation curves, VOF: venous output function, AIF: arterial input function.

* derived from 24 hour or 5/6 days NCCT follow up scan with the same co-registered coverage as the CTP.